Is TSH 0.005 Dangerous? What This Low Level Means

A TSH of 0.005 mIU/L is not just low; it is essentially undetectable, and it does signal real danger if it reflects your body’s actual thyroid status. The normal TSH range runs roughly from 0.3 to 4.0 mIU/L, so a reading of 0.005 sits far below even the bottom of that range. Whether this demands urgent action or measured adjustment depends heavily on why the number is so low, but the risks associated with a persistently suppressed TSH at this level are well documented and span the heart, bones, brain, and overall quality of life.

What a TSH This Low Actually Tells You

TSH is the signal your pituitary gland sends to the thyroid, telling it to make more hormone. When thyroid hormone levels in the blood climb too high, the pituitary dials TSH down, sometimes to near zero. A reading of 0.005 means the pituitary has essentially stopped asking for more thyroid hormone because it is already seeing far too much. In clinical shorthand, any TSH below 0.1 mIU/L is classified as “suppressed,” and guidelines place it in the more serious tier of subclinical hyperthyroidism (sometimes called grade 2) or, if free thyroid hormone levels are also elevated, overt hyperthyroidism.

The distinction matters. If your free T4 and free T3 are still within the normal range despite a TSH of 0.005, you are technically in subclinical territory, meaning the thyroid excess hasn’t fully spilled over into obviously elevated hormone levels yet. If those hormones are also high, you have overt hyperthyroidism. Either way, a TSH this low is not something to shrug off. European Thyroid Association guidelines recommend treatment for patients over 65 with grade 2 subclinical hyperthyroidism and suggest considering treatment in younger patients who have cardiovascular risk factors, persistent disease, or symptoms of thyroid hormone excess.

¹

Why Your TSH Might Be This Low

The causes of a deeply suppressed TSH fall into a few broad categories, and identifying which one applies to you changes everything about how to respond.

• Overmedication with levothyroxine: This is one of the most common reasons. If you take thyroid hormone replacement after thyroid surgery, for hypothyroidism, or for thyroid cancer, the dose may simply be too high. Data from the Baltimore Longitudinal Study of Aging found that about one in ten people on thyroid hormone therapy had a low TSH, compared with fewer than one in a hundred among untreated individuals. Women were more often overtreated than men, and in roughly a third of overtreated patients with follow-up data, the overtreatment persisted for at least two years.
²
• Graves’ disease or toxic nodules: These are the classic endogenous causes. The thyroid itself is overproducing hormone, either because of autoimmune stimulation (Graves’) or because of autonomously functioning nodules. A TSH of 0.005 is common in untreated Graves’ disease.
• Thyroiditis: Inflammation of the thyroid can temporarily dump stored hormone into the bloodstream, tanking TSH. This is usually self-limiting, resolving over weeks to months.
• Pregnancy: In the first trimester, hCG (the pregnancy hormone) structurally resembles TSH enough to stimulate the thyroid directly. This can cause gestational transient hyperthyroidism, a self-limited, non-autoimmune form of thyroid overactivity that resolves on its own and typically does not need treatment.
³
• Non-thyroidal illness and medications: In hospitalized patients, as many as 3% may show a TSH below 0.1, and in about three-quarters of those cases, the low reading is caused not by thyroid disease but by severe illness itself or by medications like glucocorticoids and dopamine that suppress TSH.

⁴

A separate study of patients over 75 found that inadequate control of thyroid function was present in over 45% of those with low TSH, and about 40% of them were not adequately treated, pointing to a widespread problem of poor follow-up and dose adjustment in older adults.

⁵

The Heart Risks Are the Most Immediate Concern

If there is one organ system where a suppressed TSH causes the most well-established harm, it is the cardiovascular system. Excess thyroid hormone speeds up the heart, increases the force of contractions, and alters how the heart muscle relaxes between beats. Over time, these changes raise the risk of abnormal rhythms, particularly atrial fibrillation.

A large population cohort study found that the risk of atrial fibrillation climbed in a stepwise fashion as TSH dropped. People with suppressed TSH had about a 40% higher risk of developing atrial fibrillation compared with those whose thyroid function was normal.

⁶

Among thyroid cancer patients specifically maintained on TSH-suppressive therapy, the picture is even more striking. One study found that about 10% of those patients had atrial fibrillation, and in patients aged 60 and over, the rate jumped to roughly 17.5%, significantly higher than what you’d expect in the general population of the same age.

⁷

Beyond rhythm problems, the heart’s structure and function can change. Research on patients whose TSH was suppressed into the 0.1–0.4 range showed increased left ventricular mass and signs of impaired diastolic function, meaning the heart had trouble relaxing and filling properly between beats.

⁸

A separate study using more sensitive imaging confirmed that diastolic dysfunction can appear even when the heart looks structurally normal by standard measures, suggesting the damage can be subtle before it becomes obvious.

⁹

A study tracking long-term outcomes in patients on thyroxine therapy found that those with suppressed TSH had a 37% higher risk of cardiovascular disease overall and a 60% higher risk of dysrhythmias compared with patients whose TSH fell within the normal range.

¹⁰

Bone Loss and Fracture Risk

Thyroid hormones speed up bone turnover. When there is too much of them circulating, the balance tips in favor of bone breakdown. The effect is gradual, so it tends to matter more the longer your TSH stays suppressed. Research suggests that long-term TSH-suppressive doses of thyroxine decrease bone mineral density and raise fracture risk, with the strongest evidence in postmenopausal women.

¹¹

There is also evidence that low TSH itself, independent of circulating thyroid hormone levels, plays a role. In humans, a single administration of TSH reduces markers of bone resorption, and population studies have found that low TSH correlates with increased fracture risk.

¹²

The long-term outcome data reinforce this: patients with suppressed TSH on thyroxine therapy had roughly double the risk of fractures compared with those in the normal TSH range.

¹⁰

Cognitive Effects and Dementia Risk

The brain is sensitive to thyroid hormone levels, and there is growing evidence that chronically low TSH is associated with cognitive decline. A study of middle-aged and older adults found that lower TSH levels were associated with worse cognition and higher odds of mild cognitive impairment, with the association appearing especially strong in men.

¹³

More concerning, a case-control study found that patients with Alzheimer’s disease had significantly lower TSH levels than controls, and low TSH was associated with more than a twofold increased risk of Alzheimer’s, independent of other risk factors.

¹⁴

A systematic review of the literature reached a similar conclusion: across more than a dozen studies, including several well-powered analyses, there was a consistent association between subclinical hyperthyroidism and cognitive impairment or dementia.

¹⁵

These findings do not prove that a suppressed TSH directly causes dementia, but the association is strong enough that it factors into clinical decisions about how aggressively to suppress TSH, especially in older adults.

Quality of Life, Anxiety, and Sleep

Even when a suppressed TSH doesn’t cause a dramatic event like atrial fibrillation or a fracture, it can grind down daily quality of life in ways that are easy to underestimate. You might feel wired but exhausted, irritable, unable to sleep well, or anxious without a clear trigger.

Research on thyroid cancer patients maintained on TSH-suppressive therapy found significantly impaired quality of life compared with the general population. Anxiety was present in about 44% of patients, and depression in roughly 18%, even while they were on stable levothyroxine doses and not acutely hypothyroid.

¹⁶

Another study looked specifically at the degree of TSH suppression and found a dose-response relationship: patients in the most suppressed group had higher anxiety scores, higher somatic symptom scores, and worse sleep quality compared with controls. The effects correlated inversely with TSH values, meaning the lower the TSH, the worse the symptoms tended to be. The researchers concluded that unnecessary oversuppression of TSH should be avoided.

¹⁷

Muscle Strength and Physical Function in Older Adults

There is an underappreciated physical consequence of extreme TSH levels. A large Brazilian study found that in older adults, TSH had a U-shaped relationship with sarcopenia (the loss of muscle mass and strength that accelerates with aging). Both the lowest and the highest TSH levels were associated with significantly higher odds of sarcopenia and low muscle strength compared with people whose TSH fell in the middle of the range.

¹⁸

For someone with a TSH of 0.005 who is already over 60, this adds another dimension of risk beyond heart rhythm and fractures. The combination of bone loss, muscle weakness, and potential cognitive decline creates a compounding vulnerability that can accelerate frailty.

When a TSH of 0.005 Is Deliberate

Not every patient with a TSH this low is there by accident. After treatment for differentiated thyroid cancer, particularly in patients considered high risk for recurrence, doctors sometimes intentionally suppress TSH to very low levels with levothyroxine. The rationale is that TSH can stimulate the growth of residual thyroid cancer cells, so keeping it near zero may slow or prevent recurrence.

The evidence that this strategy reduces cancer recurrence is reasonably strong for high-risk patients, but it comes with the full menu of side effects described above. A review of the literature concluded that in patients with high-risk thyroid cancer who also have a high risk of adverse effects, long-term TSH-suppressive therapy should be individualized, balancing cancer recurrence risk against cardiovascular, skeletal, and quality-of-life harms.

¹⁹

A more recent review reinforced this message, noting that TSH suppression is associated with cardiovascular risks, bone loss, and poor quality of life, and that any decision to suppress should be grounded in a careful assessment of recurrence risk, treatment response, and comorbidities.

²⁰

For low-risk thyroid cancer patients, clinical guidelines have increasingly moved away from aggressive TSH suppression. The European Thyroid Association recommends against treating subclinical hyperthyroidism in young, asymptomatic patients with low but detectable TSH, reflecting a shift toward less blanket suppression and more nuanced risk stratification.

¹

When the Number Might Be Wrong

Before assuming a TSH of 0.005 reflects your true thyroid status, it is worth knowing that certain substances can produce falsely abnormal thyroid test results. The most well-documented culprit is biotin (vitamin B7), which is found in many hair, skin, and nail supplements, sometimes at doses far exceeding dietary needs. Because many thyroid immunoassays use biotin-streptavidin chemistry, high-dose biotin in the blood at the time of the test can produce results that look like thyrotoxicosis, including a falsely suppressed TSH.

²¹

If you take a biotin supplement and your TSH comes back unexpectedly low, your doctor may ask you to stop the supplement for a few days and retest. Most labs now warn about biotin interference, but it still catches people off guard. As noted earlier, non-thyroidal illness in hospitalized patients and certain medications can also push TSH below normal ranges without reflecting true thyroid overactivity.

What to Expect at the Doctor’s Office

A single TSH reading of 0.005 will prompt further investigation, not an immediate diagnosis. Your doctor will order free T4 and free T3 to determine whether thyroid hormone levels are actually elevated or whether this is subclinical. They will ask about medications, supplements, recent illness, and pregnancy. Thyroid antibody tests (particularly TSH receptor antibodies) can help distinguish Graves’ disease from other causes. A thyroid uptake scan may be ordered to see whether the gland is overactive throughout (typical of Graves’) or has a hot nodule.

If you are already on levothyroxine and your TSH is 0.005, the most likely next step is a dose reduction. If the cause is endogenous (your thyroid is producing too much on its own), treatment options include antithyroid medications, radioactive iodine, or surgery, depending on the underlying diagnosis, your age, and your preferences. Beta-blockers can be used in the short term to manage symptoms like rapid heart rate and tremor while the underlying cause is being addressed.

¹

The urgency depends on context. An otherwise healthy 30-year-old with a TSH of 0.005 from a slightly excessive levothyroxine dose is in a different situation than a 70-year-old with the same reading, existing heart disease, and osteoporosis. The older patient faces compounding risks that make correction more pressing. But in neither case is a TSH of 0.005 something to ignore or recheck in six months without further workup. It warrants action now, even if that action is sometimes as straightforward as adjusting a pill dose.